Mk3475
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
2997 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | 276 | 316 | 129 | 5 | 54 | 651 |
| Neoplasms | D009369 | — | C80 | 412 | 253 | 16 | 4 | 19 | 542 |
| Melanoma | D008545 | — | — | 190 | 201 | 28 | 1 | 37 | 373 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 133 | 181 | 26 | 2 | 11 | 291 |
| Carcinoma | D002277 | — | C80.0 | 107 | 169 | 26 | 1 | 18 | 272 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 103 | 150 | 17 | 1 | 12 | 237 |
| Triple negative breast neoplasms | D064726 | — | — | 94 | 124 | 15 | 1 | 7 | 205 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | 90 | 85 | 15 | 2 | 9 | 162 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 67 | 75 | 14 | 1 | 4 | 128 |
| Adenocarcinoma | D000230 | — | — | 37 | 78 | 5 | 1 | 2 | 110 |
Show 15 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lung neoplasms | D008175 | — | C34.90 | 125 | 149 | 39 | — | 33 | 281 |
| Colorectal neoplasms | D015179 | — | — | 117 | 98 | 9 | — | 11 | 191 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 111 | 84 | 17 | — | 5 | 171 |
| Squamous cell carcinoma | D002294 | — | — | 61 | 101 | 14 | — | 7 | 155 |
| Head and neck neoplasms | D006258 | — | — | 62 | 86 | 16 | — | 5 | 136 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 70 | 76 | 5 | — | 2 | 122 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 41 | 54 | 9 | — | 18 | 103 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 41 | 52 | 10 | — | 15 | 100 |
| Transitional cell carcinoma | D002295 | — | — | 40 | 61 | 12 | — | 7 | 94 |
| Urologic neoplasms | D014571 | — | C64-C68 | 47 | 56 | 7 | — | 4 | 90 |
Show 79 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 23 | 23 | — | — | — | 35 |
| B-cell lymphoma | D016393 | — | — | 17 | 18 | — | — | 1 | 31 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 15 | 19 | — | — | — | 28 |
| Castration-resistant prostatic neoplasms | D064129 | — | — | 13 | 13 | — | — | — | 24 |
| Colonic neoplasms | D003110 | — | C18 | 16 | 15 | — | — | — | 24 |
| Pancreatic ductal carcinoma | D021441 | — | — | 14 | 15 | — | — | — | 22 |
| Follicular lymphoma | D008224 | — | C82 | 12 | 13 | — | — | — | 20 |
| T-cell lymphoma | D016399 | — | — | 9 | 15 | — | — | — | 18 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 9 | 9 | — | — | — | 16 |
| Glioma | D005910 | EFO_0000520 | — | 8 | 9 | — | — | 3 | 15 |
Show 195 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Peripheral nervous system diseases | D010523 | — | G64 | 1 | — | — | — | 4 | 5 |
| Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | 1 | — | — | — | 1 | 2 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 2 | — | — | — | — | 2 |
| Rhabdomyosarcoma | D012208 | — | — | 2 | — | — | — | — | 2 |
| Desmoplastic small round cell tumor | D058405 | — | — | 2 | — | — | — | — | 2 |
| Bites and stings | D001733 | — | — | 2 | — | — | — | — | 2 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | 1 | — | — | — | 1 | 2 |
| Medulloblastoma | D008527 | — | — | 2 | — | — | — | — | 2 |
| Motor activity | D009043 | EFO_0003940 | — | 1 | — | — | — | 1 | 2 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | — | — | — | — | 1 |
Show 42 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myocarditis | D009205 | — | I51.4 | — | — | — | — | 3 | 3 |
| Autoimmune diseases | D001327 | EFO_0000540 | M30-M36 | — | — | — | — | 3 | 3 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | — | — | 2 | 2 |
| Human influenza | D007251 | EFO_0007328 | J11.1 | — | — | — | — | 2 | 2 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 1 | 1 |
| Cardiomyopathies | D009202 | EFO_0000318 | I42 | — | — | — | — | 1 | 1 |
| Pericarditis | D010493 | EFO_0007427 | I30 | — | — | — | — | 1 | 1 |
| Vasculitis | D014657 | EFO_0006803 | M31 | — | — | — | — | 1 | 1 |
| Myositis | D009220 | EFO_0000783 | G72.49 | — | — | — | — | 1 | 1 |
| Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | — | — | 1 | 1 |
Show 20 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use